Search results
Results from the WOW.Com Content Network
RFA One is a small-lift multistage launch vehicle with an on-orbit transfer stage designed to transport small and micro-s atellites of up to 1,300 kg into low-Earth polar and Sun-synchronous orbits. It has been in development by German private company Rocket Factory Augsburg since 2019.
Resonance frequency analysis was first suggested as an alternative method of analyzing peri-implant bone in a scientific paper by Meredith N et al in 1996. [4] As stated in the paper’s abstract, in measuring implant stability and osseointegration, “radiographs are of value, but a standardised technique is necessary to ensure repeatability.” [4] The new technique tested involved ...
Engine Origin Designer Vehicle Use Propellant Power cycle Specific impulse (s) [a] Thrust (N) [a] Chamber pressure (bar) Mass (kg) Thrust: weight ratio [e] Oxidiser: fuel ratio ...
The development of heated humidified high flow started in 1999 with Vapotherm introducing the concept of high flow use with race horses. [2]High flow was approved by the U.S. Food and Drug Administration in the early 2000s and used as an alternative to positive airway pressure for treatment of apnea of prematurity in neonates. [3]
Radiofrequency ablation (RFA), also called fulguration, [1] is a medical procedure in which part of the electrical conduction system of the heart, tumor, sensory nerves or a dysfunctional tissue is ablated using the heat generated from medium frequency alternating current (in the range of 350–500 kHz).
The PRISMA flow diagram, depicting the flow of information through the different phases of a systematic review. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) is an evidence-based minimum set of items aimed at helping scientific authors to report a wide array of systematic reviews and meta-analyses, primarily used to assess the benefits and harms of a health care ...
Rocket Factory Augsburg was founded as a spin-off of OHB SE in 2018 by Jörn Spurmann (CCO of RFA), Stefan Brieschenk (COO of RFA), Hans Steiniger (CEO of MT Aerospace) and Marco Fuchs (CEO of OHB SE). [6] As of 2021, Spurmann, Brieschenk, Steiniger, Fuchs, Stefan Tweraser (CEO of RFA), and Jean-Jacques Dordain made up the board of RFA.
IC 50 values are typically expressed as molar concentration. IC 50 is commonly used as a measure of antagonist drug potency in pharmacological research. IC 50 is comparable to other measures of potency, such as EC 50 for excitatory drugs. EC 50 represents the dose or plasma concentration required for obtaining 50% of a maximum effect in vivo. [1]